✅ Model Answer:
• Thick-walled cavity in the left lower lobe.
• Air-fluid level within the cavity (horizontal interface).
• Surrounding consolidation / infiltrates.
• Irregular, thick inner wall (contrast with thin-walled pneumatocele).
• May have adjacent pleural reaction.
• Diagnosis: Pulmonary abscess (left lower lobe).

✅ Model Answer:
• Lung abscess: Necrotizing infection with tissue necrosis and cavity formation. Thick-walled cavity with air-fluid level. Usually due to anaerobic bacteria (aspiration), Staphylococcus aureus, or Streptococcus pneumoniae.
• Pneumatocele: Thin-walled, air-filled cyst that forms after pneumonia. Usually caused by Staphylococcus aureus or Pneumocystis jirovecii. Contains air without a fluid level (unless infected). Thin-walled and may resolve spontaneously.
• Key difference: Lung abscess has thick walls and an air-fluid level; pneumatocele has thin walls and contains air.

✅ Model Answer:
• Common organisms:
- Oral anaerobes (Fusobacterium, Peptostreptococcus, Prevotella, Bacteroides) – most common, especially in aspiration.
- Staphylococcus aureus – common in children.
- Streptococcus pneumoniae.
- Klebsiella pneumoniae – more common in adults.
- Mycobacterium tuberculosis – in endemic areas.
• Foul-smelling sputum: Highly suggestive of anaerobic infection (Fusobacterium, Peptostreptococcus).

✅ Model Answer:
• Fever – high-grade, persistent.
• Productive cough – may be foul-smelling (anaerobes).
• Chest pain – pleuritic, may be localized.
• Weight loss and poor appetite – chronic infection.
• Malaise and fatigue.
• Hemoptysis – may occur (sometimes massive).
• Dullness and crackles on auscultation – over the affected area.
• Clubbing – in chronic cases.

✅ Model Answer:
• Empiric IV antibiotic therapy:
- Clindamycin 30-40 mg/kg/day IV (divided q6-8h) – covers oral anaerobes and Streptococcus.
- Ampicillin-sulbactam 100-200 mg/kg/day IV – covers anaerobes and Gram-positive organisms.
- If Staphylococcus aureus is suspected: Add vancomycin (or nafcillin if MSSA).
• Duration: 2-3 weeks IV, then 3-4 weeks oral (total 3-4 weeks).
• If TB is suspected: Add anti-TB therapy (isoniazid, rifampin, pyrazinamide, ethambutol).

✅ Model Answer:
• Large abscess (>4-6 cm in diameter).
• Failure of antibiotics (no improvement after 7-10 days of IV therapy).
• Development of complications (bronchopleural fistula, empyema).
• Respiratory distress due to mass effect.
• Accessible location (non-central) for safe drainage.
• CT-guided pigtail catheter drainage is preferred.

✅ Model Answer:
• Failure of antibiotics + percutaneous drainage.
• Massive hemoptysis (life-threatening).
• Bronchopleural fistula with persistent air leak.
• Empyema that cannot be drained.
• Underlying malignancy or foreign body.
• Location not amenable to percutaneous drainage.
• Recurrent infection after initial treatment.

✅ Model Answer:
• Lung abscess: Acute/subacute onset, fever, productive cough (often foul-smelling), air-fluid level, thick-walled cavity, lower lobe (aspiration-prone). Culture: anaerobic bacteria, S. aureus, S. pneumoniae.
• Tuberculous cavity: Chronic symptoms (weight loss, night sweats, hemoptysis), thin-walled cavity, upper lobe predominance, no air-fluid level (usually), hilar lymphadenopathy, positive PPD/IGRA, AFB smear/culture positive.
• Radiological: TB cavities have thinner walls and are typically in apical or posterior segments of upper lobes.

✅ Model Answer:
• Empyema – infection spreading to the pleural space.
• Bronchopleural fistula – communication between the abscess and pleural space.
• Hemoptysis – can be massive and life-threatening.
• Recurrent infection – due to inadequate drainage or treatment.
• Cavity persistence – may require surgical resection.
• Septicemia – rare but serious.

✅ Model Answer:
• Adjunctive therapy for lung abscess.
• Promotes drainage of purulent material.
• Position the patient to facilitate drainage (e.g., head-down for lower lobe abscesses).
• Contraindicated in massive hemoptysis or bronchopleural fistula.
• May be used in combination with antibiotics.
• Effectiveness is variable; not a substitute for antibiotics or drainage.

✅ Model Answer:
• Evaluate for complications: Empyema, bronchopleural fistula, foreign body, underlying lung disease.
• CT scan of the chest – to assess abscess size, location, and complications.
• Consider CT-guided percutaneous drainage – if abscess is large (>4-6 cm) and accessible.
• Review antibiotic coverage – consider broadening (e.g., add vancomycin for MRSA, anti-TB therapy).
• Consider bronchoscopy – to rule out foreign body or obtain cultures.
• Surgical consultation – if drainage fails or if there is an underlying lesion.

✅ Model Answer:
• Total duration: 3-4 weeks.
• IV antibiotics: 2-3 weeks (until the patient is afebrile and clinically improved).
• Oral antibiotics: Continue for a total of 3-4 weeks.
• Follow-up CXR: Should be repeated to confirm resolution of the cavity.
• If the cavity persists but is smaller, antibiotics may be extended.
• If the cavity does not resolve, consider other causes (e.g., TB, fungal infection).